xB3-004

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamexB3-004

Drug Alias NamexB3-004

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > ImmunoglobulinBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionInterleukin-1 receptor antagonists

TargetsInterleukin-1 receptor

Therapy Area/IndicationsPainNeuralgiaNeurodegenerative Diseases +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedimmune

China Registration ClassN/A

Develop Information

Active CompaniesMedimmune

Inactive CompaniesN/A

Active IndicationsPainNeuralgiaNeurodegenerative Diseases +[6]

Inactive IndicationsN/A

Other Information

ATC CodeN/A